Join
Live feed
·
PRReleasevia Quantisnow
NAYA Biosciences Inc. logo

NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody

ByQuantisnow·Wall Street's wire, on your screen.
NAYA· NAYA Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAYA (NAYA Biosciences Inc.) and more on Quantisnow.